Former Chief Financial Officer and Chief Accounting Officer · NEKTAR THERAPEUTICS (NKTR)

Jillian Thomsen

A named executive officer of NEKTAR THERAPEUTICS in every fiscal year CompBrief holds from FY2018 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,239,759

Salary $355,760Stock awards $0

FY2022: $4,558,317

3rd of 5 named executive officers at Nektar Therapeutics by FY2023 total.

5 named officers on file for NEKTAR THERAPEUTICS, FY2023

Jillian Thomsen’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 10 equity grants, each cited to its filing
  • NKTR’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how NEKTAR THERAPEUTICS’s whole pay program stands against its peers

  • NEKTAR THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NKTR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2024 (DEF 14A).

Free

Get Jillian Thomsen’s full pay file as a PDF — free

More than this page: up to 10 years of Jillian’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jillian Thomsen compensation by year

NEKTAR THERAPEUTICS Summary Compensation Table · all 4 fiscal years held
In US dollars, as NEKTAR THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2022FY2023
Salary$435,000$457,000$522,200$355,760
Bonus$0—$0$0
Stock awards$4,461,657$649,340$1,629,478$0
Option awards$899,490$795,957$2,185,994$0
Non-equity incentive$424,100$0$198,000$0
Pension and deferred compensation$0$0$0$0
All other$13,347$13,787$22,645$883,999
Total$6,233,595$1,916,084$4,558,317$1,239,759

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NEKTAR THERAPEUTICS DEF 14A filed April 26, 2024, accession 0001140361-24-022440, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NEKTAR THERAPEUTICS filed document, accession 0001140361-24-022440. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.

$6.2M
$1.9M
$4.6M
$1.2M
FY18
FY19
FY22
FY23
SalaryNon-equity incentiveStock awardsOption awardsAll other

NEKTAR THERAPEUTICS’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Howard RobinPresident and Chief Executive Officer$3,135,576
Jonathan ZalevskyChief Research and Development Officer$1,773,364
Jillian Thomsen · this pageFormer Chief Financial Officer and Chief Accounting Officer$1,239,759
Mark WilsonFormer Chief Legal Officer$1,100,468
Sandra GardinerInterim Chief Financial Officer$376,300

The full NEKTAR THERAPEUTICS compensation record

free company brief

This page is one person within NEKTAR THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the NEKTAR THERAPEUTICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NEKTAR THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jillian Thomsen's compensation dossier · One-time report. No refunds.